Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 4/20 | 0.34 |
| ▸ | MAOA | P21397 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6129709 | 1.00 | CHRM2 (0.40) | CHRM2CHRM4CHRM1CHRM3CHRM5 | |
| Terephthalic Acid SCHEMBL7901428 | 0.84 | TSHR (0.46) | — | |
| Propylene Glycol SCHEMBL10865600 | 0.82 | TDP1 (0.36) | CHRM2CHRM4CHRM1CHRM3CHRM5 | |
| SCHEMBL3471203 | 0.78 | CHRM2 (0.36) | CHRM2CHRM4CHRM1CHRM3CHRM5 | |
| SCHEMBL2763761 | 0.77 | CHRNB2 (0.39) | OPRL1CHRNB2SLC6A2CHRNB4CHRNA3 | |
| SCHEMBL28366383 | 0.77 | CHRNB2 (0.39) | OPRL1CHRNB2SLC6A2CHRNB4CHRNA3 | |
| SCHEMBL2763759 | 0.77 | CHRNB2 (0.39) | OPRL1CHRNB2SLC6A2CHRNB4CHRNA3 | |
| SCHEMBL10362472 | 0.77 | SLC6A3 (0.41) | CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3971547 | 0.75 | CHRM2 (0.49) | CHRM2CHRM4CHRM1CHRM3CHRM5 | |
| SCHEMBL7108506 | 0.75 | CHRM2 (0.49) | CHRM2CHRM4CHRM1CHRM3CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011003898-A1 | TONER RESINS FOR ELECTRONIC COPYING PURPOSES | BASF SE (DE) | 2011-01-13 | — | — | WO | claimed |
| US-20220202744-A1 | METHODS OF TREATING MENTAL DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-30 | — | — | US | disclosed |
| WO-2021039585-A1 | POLARIZATION FILM LAMINATE PROVIDED WITH ADHESIVE LAYER, AND OPTICAL DISPLAY PANEL IN WHICH POLARIZATION FILM LAMINATE PROVIDED WITH ADHESIVE LAYER IS USED | 日東電工株式会社 | 2021-03-04 | — | — | WO | disclosed |
| WO-2021039583-A1 | POLARIZING FILM LAMINATE WITH ADHESIVE LAYER AND OPTICAL DISPLAY PANEL IN WHICH SAID POLARIZING FILM LAMINATE WITH ADHESIVE LAYER IS USED | 日東電工株式会社 | 2021-03-04 | — | — | WO | disclosed |
| US-10696845-B2 | Energy-sensitive resin composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| EP-3275940-B1 | ENERGY-SENSITIVE RESIN COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2019-12-18 | — | — | EP | disclosed |
| US-20190225804-A1 | ENERGY-SENSITIVE RESIN COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-25 | — | — | US | disclosed |
| US-10322118-B2 | Compounds and methods for inhibiting Cif virulence factor | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2019-06-18 | — | — | US | disclosed |
| EP-3275940-A1 | ENERGY-SENSITIVE RESIN COMPOSITION | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2018-01-31 | — | — | EP | disclosed |
| EP-2528604-B1 | ACYL PIPERIDINE INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE | UNIV CALIFORNIA (US) | 2017-11-22 | — | — | EP | disclosed |
| US-5714294-A | A SHELL-CORE CROSSLINKED COPOLYMER PARTICLES COMPRISING A VINYL MONOMER AND AN ACRYLIC ACID ESTER AND/OR METHACRYLIC ACID ESTER OR DIENE MONOMERS; FIXABLE AT LOW TEMPERATURE, IMPACT STRENGTH, STABILITY, DURABILITY | KAO CORPORATION (JP) | 1998-02-03 | — | — | US | disclosed |
| EP-0794230-A2 | Curable composition based on silyl-functionalized polyethers and epoxy resins | Kaneka Corporation (JP) | 1997-09-10 | — | — | EP | disclosed |
| US-5068248-A | Analgesics, antipyretics and antiinflammatory agents | MERCK & CO., INC. (US) | 1991-11-26 | — | — | US | disclosed |
| EP-0160408-B1 | BENZOTHIOPHENES, THEIR PRODUCTION AND USE, AND COMPOSITIONS CONTAINING THEM | MERCK & CO. INC. (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4760086-A | N-alkenyl-3-hydroxybenzo[b]thiophene-2-carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors | MERCK & CO., INC. (US) | 1988-07-26 | — | — | US | disclosed |
| EP-0160408-A1 | Benzothiophenes, their production and use, and compositions containing them | MERCK & CO. INC. (US) | 1985-11-06 | — | — | EP | disclosed |
| US-4186255-A | POLYURETHANE CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| US-4136240-A | METALLIC QUATERNARY AMMONIUM CARBOXYLATES AS POLYISOCYANURATE CATALYSTS | TEXACO DEVELOPMENT CORPORATION (US) | 1979-01-23 | — | — | US | disclosed |
| US-4075130-A | DIAMINES, TRIAMINES | TEXACO DEVELOPMENT CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
| US-4060501-A | Novolak derivatives as defoamers | TEXACO DEVELOPMENT CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202744-A1 | METHODS OF TREATING MENTAL DISORDERS | FAAH, EPHX1, FAAH2 | CHRM2 508/4885CHRM4 306/4885CHRM1 529/4885 |
| US-10322118-B2 | Compounds and methods for inhibiting Cif virulence factor | CFTR, NCF1, CFB | CHRM2 4245/4885CHRM4 3832/4885CHRM1 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.